149 related articles for article (PubMed ID: 15619026)
41. Socioeconomic status and the incidence of ESRD.
Ward MM
Am J Kidney Dis; 2008 Apr; 51(4):563-72. PubMed ID: 18371532
[TBL] [Abstract][Full Text] [Related]
42. End-stage renal disease and its treatment in Latin America in the twenty-first century.
Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
[TBL] [Abstract][Full Text] [Related]
43. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
44. Racial differences in trends of end-stage renal disease, by primary diagnosis--United States, 1994-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(11):253-6. PubMed ID: 17380108
[TBL] [Abstract][Full Text] [Related]
45. Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations.
McQueen MJ
Scand J Clin Lab Invest Suppl; 2008; 241():52-6. PubMed ID: 18569965
[TBL] [Abstract][Full Text] [Related]
46. Trends in end-stage renal disease. Epidemiology, morbidity, and mortality.
Reikes ST
Postgrad Med; 2000 Jul; 108(1):124-6, 129-31, 135-6 passim. PubMed ID: 10914123
[TBL] [Abstract][Full Text] [Related]
47. The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus.
Rychlík I; Miltenberger-Miltenyi G; Ritz E
Nephrol Dial Transplant; 1998; 13 Suppl 8():6-10. PubMed ID: 9870418
[TBL] [Abstract][Full Text] [Related]
48. Primary health care strategies for the prevention of end-stage renal disease in Cuba.
Almaguer M; Herrera R; Alfonso J; Magrans C; Mañalich R; Martínez A
Kidney Int Suppl; 2005 Aug; (97):S4-10. PubMed ID: 16014098
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology of end-stage renal disease in Iran: a review article.
Mousavi SS; Soleimani A; Mousavi MB
Saudi J Kidney Dis Transpl; 2014 May; 25(3):697-702. PubMed ID: 24821181
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and socio-economic aspects of chronic kidney disease.
Bommer J
Nephrol Dial Transplant; 2002; 17 Suppl 11():8-12. PubMed ID: 12386249
[TBL] [Abstract][Full Text] [Related]
51. Prevention of renal failure: the Malaysian experience.
Hooi LS; Wong HS; Morad Z
Kidney Int Suppl; 2005 Apr; 67(94):S70-4. PubMed ID: 15752245
[TBL] [Abstract][Full Text] [Related]
52. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease Bethesda (MA) April 1994.
Striker GE
Nephrol Dial Transplant; 1995; 10(2):290-2. PubMed ID: 7753470
[No Abstract] [Full Text] [Related]
53. Prevention of the progression of chronic kidney disease: practice in China.
Wang H; Zhang L; Lv J
Kidney Int Suppl; 2005 Apr; (94):S63-7. PubMed ID: 15752243
[TBL] [Abstract][Full Text] [Related]
54. End-stage renal disease.
Parker T; Hakim R; Ismail N
Semin Nephrol; 1997 Jul; 17(4):253-6. PubMed ID: 9241711
[No Abstract] [Full Text] [Related]
55. Obesity-related glomerulopathy: another nail in the coffin of the epidemic of end-stage renal disease.
Ahmed MH; Khalil AA
J Clin Pathol; 2007 May; 60(5):582. PubMed ID: 17513523
[No Abstract] [Full Text] [Related]
56. [Large volume increase in a trastigian kidney].
Curatola G; Ciccarelli M; Finocchiaro P
G Ital Nefrol; 2004; 21(4):371-3. PubMed ID: 15470663
[TBL] [Abstract][Full Text] [Related]
57. Taking a public health approach to the prevention of end-stage renal disease: the NKF Singapore Program.
Ramirez SP; Hsu SI; McClellan W
Kidney Int Suppl; 2003 Feb; (83):S61-5. PubMed ID: 12864877
[TBL] [Abstract][Full Text] [Related]
58. Current burden and probable increasing incidence of ESRD in China.
Zuo L; Wang M;
Clin Nephrol; 2010 Nov; 74 Suppl 1():S20-2. PubMed ID: 20979958
[TBL] [Abstract][Full Text] [Related]
59. [Current strategy for ESRD in Japan].
Akizawa T
Nihon Jinzo Gakkai Shi; 2006; 48(8):715-8. PubMed ID: 17184021
[No Abstract] [Full Text] [Related]
60. The changing patterns of chronic kidney disease: the need to develop strategies for prevention relevant to different regions and countries.
Atkins RC
Kidney Int Suppl; 2005 Sep; (98):S83-5. PubMed ID: 16108978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
